| NEURONETICS INC. DL-,01 |
| USA |
| Gesundheit |
| US64131A1051 / A2JPMY |
| NRC (Frankfurt) / STIM (NASDAQ) |
| FRA:NRC, ETR:NRC, NRC:GR, NASDAQ:STIM |
| - |
| https://neurostar.com/ |
|
Neuronetics Inc. is a commercial-stage medical technology company focused on non-invasive neurohealth treatments. Its core offering is the NeuroStar Advanced Therapy System, an office-based transcranial magnetic stimulation platform used primarily fo..
>Volltext.. |
| 139.69 Mio. EUR |
| 196.46 Mio. EUR |
| 138.02 Mio. EUR |
| -17.56 Mio. EUR |
| -27.08 Mio. EUR |
| -0.39 EUR |
| 77 Mio. EUR |
| 22.2 Mio. EUR |
| -9.22 Mio. EUR |
| 0.89 |
| 43.98% |
| 35% |
| - |
| - |
| - |
| NEURONETICS |
| 04.11.26 |
|